FDA offers advice to reduce risks of long-acting beta-agonists in asthma care

JAMA. 2010 Apr 14;303(14):1353-4. doi: 10.1001/jama.2010.357.
No abstract available

Publication types

  • News

MeSH terms

  • Adrenal Cortex Hormones / adverse effects*
  • Adrenal Cortex Hormones / pharmacology
  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic beta-Agonists / adverse effects*
  • Adrenergic beta-Agonists / pharmacology
  • Adrenergic beta-Agonists / therapeutic use
  • Asthma / drug therapy*
  • Drug Interactions
  • Drug Labeling*
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-Agonists